Tranexamic Acid for the Prevention of Obstetrical Hemorrhage After Cesarean
Status:
Recruiting
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
A randomized placebo-controlled trial of 11,000 women to assess whether tranexamic acid as
prophylaxis lowers the risk of postpartum hemorrhage in women undergoing a cesarean delivery.
Phase:
Phase 3
Details
Lead Sponsor:
The George Washington University Biostatistics Center
Collaborator:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)